This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
At the JAMA Network, we are interested in providing our readers the most seamless access to the research, opinion, and clinical educational content we publish,” said Vida Damijonaitis, JAMA Network Director of Worldwide Sales. NEJM is recognized as the world’s leading medical journal and website.
The agencies holding this status have been approved and validated as compliant and committed to upholding the “highest level of regulatory standards and practices for quality, safety and efficacy of medicines and vaccines ”.
The European Medicines Agency (EMA) has published recommendations to increase communication and planning efforts in a bid stop the current medicine shortages becoming even worse. The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain.
Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. Medicines and medical technology manufacturing delivered annual exports worth over £30 billion ($37 billion) for the UK in 2019, on top of making a £32.1 It’s not all bad news.
Sandoz] has the only major remaining vertically-integrated production network for penicillins in Europe” Penicillins are the leading category of antibiotics worldwide, Sandoz highlighted. The post Sandoz mobilises critical medicine production in Europe appeared first on European Pharmaceutical Review.
Acquisition highlights companies shared commitment to clients, workplace culture, and attracting the industrys best people TORONTO, ON/SARATOGA SPRINGS, NY January 7, 2025 Klick Health today announced it has acquired Peregrine Market Access, a leading market access strategy and value communications specialist in life sciences.
One of those is sports medicine. As we celebrate International Men’s Day, Samuel Adeyinka interviews Jordan Rawlins about the world of orthopedics, namely sports medicine. What are the different roles in sports medicine medical sales and what do you need to prepare to ensure success in this space? What are you selling?
In his over 11-year tenure at Pfizer thus far, Dr Boshoff he has delivered 24 approved innovative medicines and biosimilars in over 30 indications, according to Pfizer. “Dr Academy of Medical Sciences. “I Furthermore, Dr Roger Dansey will become Interim Chief Oncology Officer, from 1 January 2025.
A report from the Advanced Therapies Treatment Centre (ATTC) Network has highlighted urgent need for rapid change and improvement in the field to maximise patient access to advanced therapies. It was compiled based on expertise gathered at the ATTC Network’s UK Advanced Therapies Adoption Challenge event in October.
billion, leading to $13.6 The study found that if certain adults received medically-tailored meals, about 1.6 million hospitalizations would have been avoided, resulting in $38.7 billion saved in healthcare expenditures. Programs to provide these meals would have cost $24.8 billion in net savings, according to the report.
The clinic will develop pre-clinical studies into early and late phase clinical trials to identify US Food and Drug Administration (FDA)-approved advanced regenerative medicines. The Cedars-Sinai Board of Governors Regenerative Medicine Institute and the Smidt Heart Institute will lead the project.
Dr Florian Bieber, Development Platform Head, Biopharmaceuticals, and Chief Medical Officer of Sandoz stated that investment will help to position the site as part of a “growing network of BioTD centres.” These conditions include rheumatic diseases, Crohn’s disease, ulcerative colitis (UC), plaque psoriasis and hidradenitis suppurativa.
Maja Pedersen has been appointed as Chief Quality Officer (CQO), to lead FUJIFILM Diosynth Biotechnologies’ global quality team. She explained: “I am thrilled to be joining FUJIFILM Diosynth Biotechnologies again and becoming an integral part of leading our teams to develop and embed a transformational quality culture.” “We
To be a superpower globally, the UK life sciences sector must not only discover and develop medicines of the future domestically, but also manufacture a significant share in the country too, according to a new report from the Medicines Manufacturing Industry Partnership (MMIP). It provides almost 45 percent of the £36.9
With over 90,000 employees across the globe, Sanofi supplies over 5 billion doses of medicines and vaccines every year, supporting the health needs of millions of patients in more than 170 countries. This will not only transform the practice of medicine, but will transform ourselves as an organisation. Standardise manufacturing .
The network aims to build a comprehensive contextual understanding of situational data in each National Hub to identify opportunities to address existing gaps and challenges. Each hub has specific and complementary multidisciplinary research expertise.
For marketing executives, understanding the significance of leading pharma brands is essential. Companies like Pfizer, Roche, and Johnson & Johnson not only lead in sales but also innovate in marketing strategies that connect with both healthcare professionals and consumers. How do personalized medicines impact pharma marketing?
CSL’s gene therapy for haemophilia B has been recommended for approval by the EMA’s human medicine committee, setting up a decision by the European Commission early next year. million – making it the most expensive medicine in the world – which was above the $2.9 CSL launched the therapy in the US with a list price of $3.5
Designing and maintaining a high-performing provider network is difficult; not because there is a shortage of great providers practicing medicine in caring, cost-effective, and patient-centric ways. This is akin to adding providers to your network without reliable data. Is that worth the price?
The scheme aims to support UK advanced therapy medicinal product (ATMP) clinical trials. Specifically, an additional four years of funding for the Advanced Therapy Treatment Centre (ATTC) Network is available through the programme. What key solutions will the investment in the Advanced Therapy Treatment Centre Network provide?
Sam Cooper, the senior district Sales Manager for InMode, joins us to share his remarkable journey from copier sales to becoming a leading figure in the aesthetic medical sales industry. He emphasizes the importance of hard work, networking, and achieving natural-looking results.
Given the funding environment for innovative medicines that is faced by all pharma, large or small, once assets are approved, however, this 2023 reset seems a necessary response. Medicines manufacturing is energy intensive. Medicines distribution and supply is also an energy intensive and regulated business.
The Rockville facility will join AstraZeneca’s global manufacturing and supply network of nearly 30 manufacturing and supply sites in 16 countries. This facilitates the delivery of more than nine billion doses of medicines annually.
National Institute for Health and Care Research (NIHR)’s Clinical Research Network. It will also involve experts in infectious diseases and virology who will monitor the flu virus to see if it becomes resistant to the anti-viral drugs tested in the trial.
The DDiCT project will be co-led by Bristol Myers Squibb (BMS)’s Disability Advancement Workplace Network (DAWN) and the Global Drug Development Team. Therefore, it is essential that we broaden the scope of medical trials and research,” commented Tinamarie Duff, DAWN Global People & Business Resource Group Lead.
These cuts due to Covid-19-related deficits can potentially harm research funding, says Poppy Lamberton, PhD, Reader at the Institute of Biodiversity, Animal Health & Comparative Medicine at the University of Glasgow. However, some big pharma players have a history of donating some treatments to the cause, he explains.
Moderna will join the IBM Quantum Network and the IBM Quantum Accelerator programme. Moderna CEO Stéphane Bancel said: “Since our inception, we have always strived to be at the forefront of cutting-edge technology, leveraging innovations to deliver the greatest possible impact to people through mRNA medicines.
DSV’s involvement will provide pre-seed capital for the new ventures, which will be incubated within Cancer Research Horizon’s wet labs with support from scientists among its researcher network. The post Cancer Research UK partnership aims to back 10 new startups appeared first on.
By remaining compliant, medicines are manufactured in line with their pre-defined and approved specifications, in order to ensure the delivery of safe and effective products to consumers. Regulatory requirements are in place to ensure medicines are safe for consumption. The dominion of data. Cybersecurity and non-conformance.
Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. What types of medicinal products are in short supply and why?
As the world now looks to a post-pandemic future, despite the counterfeit medicine trade showing no signs of slowing, industry bodies must come together to tackle the production and trade of fake products. There is also the challenge of falsified medicines – the fake, unauthorised medical products that make their way into the market.
However, they hypothesised that using starches from different botanical origin would lead to different drug release kinetics. “We We observed the importance of the botanic origin of the starch in practically all the properties, such as porous microstructure, the formation of a stable network or the release of the drug,” said González. “In
The next wave of medicine is well on course to be cell and gene-based. In September 2021, GlobalData figures revealed there to be 1,320 industry-sponsored regenerative medicine and advanced therapy trials ongoing worldwide. Meanwhile, the pharma industry is undergoing somewhat of a transformation itself.
Dr Nicola Rose, Deputy Director for Research and Development at the MHRA explained: “The study of microbes associated with the human body has the potential to [allow] us to move towards a new era of personalised medicines. Synthetic data in clinical trials.
This creates a need for flexible and scalable software tools for data processing, according to Robin Schmid from Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) and UC San Diego (CA, USA), project lead architect and one of the first authors of the paper.
Sandoz, a division of Novartis , has signed a Memorandum of Understanding (MoU) for constructing a new biologics production plant in Lendava, Slovenia, to support the growing demand for biosimilar medicines worldwide. At Sandoz, we are determined to continue leading the way in driving access to these critical medicines.
Cell One Partners has announced a strategic collaboration with the Center for Breakthrough Medicines (CBM) to expedite the development and commercialisation of cell and gene therapies. Cell One Partners offers virtual company creation and management to its clients for complete aspects of the development and commercialisation of drugs.
Digital Health Networks announced its lineup of features and audio storytelling for the Cinehealth International Health and Wellness Film and Video Festival. This year’s festival takes place live in Philadelphia at Digital Pharma East on September 12 th , followed by a virtual segment at Digital Health Networks ( www.dhn.tv ).
He has worked within life sciences organizations, leading publishers, consultancies, agencies, digital health, and technology solutions support our journeys through illness and to wellness. He often speaks and writes about his passion, EaaM – Experience as a Medicine.
She is the Global Lead for the rFC implementation project and is an active contributor to the Analytical Technology Centers within Roche’s Global QC network. She serves as the global lead for the expert network team specialising in endotoxins and pyrogen testing.
Personalized Medicine AI can help develop precision medicine by analyzing patient data , including demographic, clinical, and genetic information, as well as information about their metabolism and microbes, environmental exposures, and lifestyle factors, to predict how different patients will respond to various therapies.
Notably, gut microbiome was found to linked to cancer CAR T therapy response, based data from the largest prospective study of its kind, published in Nature Medicine in March 2023. Based on current innovations, “this is the era of personalised medicine,” according to Silber. coli strains in the gut”.
CineHealth brings discussion about content and storytelling from key industry thought leaders to leading healthcare conference. The panel will be hosted by Digital Health Networks CEO, Jon Cody and will include: Nathalie Casthely: 2023 CINEHEALTH Finalist, Senior Director, Communications, Cancer Support Community Dr. Don S.
Experts from top life sciences companies discussed strategies for more effectively engaging oncologists at the Pharma Marketing Network’s 2022 Future Forecast on January 25 th. Lead with clinical education. The post Top 3 Things to Know About Engaging Oncologists in 2022 appeared first on Pharma Marketing Network.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content